Neoadjuvant and Adjuvant Systemic Therapy for Newly Diagnosed Stage II-IV Epithelial Ovary, Fallopian Tube, or Primary Peritoneal Carcinoma: A Practice Guideline.
Hal W HirteRaymond PoonXiaomei YaoTaymaa MayJosee-Lyne EthierLauri PetzJane SpeakmanLaurie ElitPublished in: Current oncology (Toronto, Ont.) (2022)
The recommendations represent a current standard of care that is feasible to implement and valued by both clinicians and patients.